Australia, Sept. 25 -- FEDERATED BIOLOGICS Pty. Ltd., owns the trademark (2626152) for 'FEDERATED BIOLOGICS' till Feb. 16, 2036.

Status: registered: Registered/protected

Classes: 1 [active chemical agents for the manufacture of pharmaceuticals; active chemical ingredients; active chemical ingredients for use in the manufacture of cosmetic products; active chemical ingredients for use in the manufacture of personal care products; active chemical ingredients for use in the manufacture of pharmaceuticals; antibodies for use in the manufacture of active ingredients of pharmaceuticals; antibodies for use in the manufacture of active ingredients of vaccines; antibody reagents for scientific purposes; biological preparations for use in biotechnology, other than for medical use; biological preparations for use in cell cultures, other than for medical purposes; cell culture media for laboratory use; cell culture media for scientific or research purposes; cell culture media for use in the biotechnological industry; cell culture reagents for scientific or research purposes; cell growth media for growing cells for use in scientific research; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; chemical preparations for use in the production of medicines; chemical products for manufacturing medical preparations; chemicals for use in biotechnological manufacturing processes; monoclonal antibodies for in vitro scientific or research purposes; monoclonal antibodies for in vitro scientific research; monoclonal antibodies for scientific purposes; monoclonal antibodies for scientific use; reagents for the development of monoclonal antibodies for research purposes; reagents for the development of monoclonal antibodies for scientific purposes], 5 [anti-viral vaccines; antibacterial vaccines; antibodies for medical purposes; antivirals; biochemical drugs; biochemical preparations for medical use; biological preparations for use in cell cultures for medical purposes; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes; biotechnological preparations for medical use; cell culture media for medical purposes; cell growth media for growing cells for medical purposes; chemical preparations for therapeutical purposes; chemical preparations for therapeutical use; chemical products for pharmaceutical purposes; chemical products for therapeutical purposes; chemical products for therapeutical use; drugs for medical purposes; drugs for medical use; immunological antibodies for medical purposes; immunological antibodies for medical use; medicinal preparations and substances; medicinal preparations for the treatment of infectious diseases; medicinal preparations for use in oncology; medicines; medicines for human purposes; medicines for human use; pharmaceutical drugs; pharmaceutical preparations containing active chemical ingredients; pharmaceutical preparations containing amino acids; pharmaceutical preparations for health care; pharmaceutical preparations for the treatment of various diseases; pharmaceutical products and preparations; pharmaceutical products for use by humans; pharmaceutical substances; pharmaceuticals; reagents for the development of monoclonal antibodies for medical purposes; therapeutic drugs and agents; vaccine preparations; vaccines], 40 [biomanufacturing of pharmaceuticals for others using biological organisms in the manufacturing process; custom biomanufacturing of cultured cell tissues; custom biomanufacturing of cultured cells; custom biomanufacturing of cultured ex vivo cell lines; custom biomanufacturing of pharmaceutical preparations; custom biomanufacturing of pharmaceutical products; custom biomanufacturing of pharmaceuticals; custom biomanufacturing of vaccines for preventing infectious diseases; custom biomanufacturing of vaccines for treating infectious diseases; custom manufacturing of RNA molecules for use in antibodies; custom manufacturing of antibody-drug conjugates; custom manufacturing of biomedical preparations; custom manufacturing of biopharmaceuticals; custom manufacturing of mRNA for use in antibodies; custom manufacturing of pharmaceutical preparations; custom manufacturing of pharmaceuticals; treatment of chemicals] and 42 [biochemical research and development; biomedical research; biotechnological research; biotechnology development; biotechnology research; cell culture services for scientific and research purposes for others; cell culturing for scientific research purposes; clinical research; consultancy in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; consulting services in the field of biotechnology; design and development of new products; development of new products; development of pharmaceutical preparations and medicines; development of pharmaceuticals; development of products for others in the field of pharmaceuticals; drug development; laboratory services for biomanufacturing; laboratory services for the production of pharmaceuticals; laboratory services for the production of vaccines; medical research; medical research and development; pharmaceutical drug development services; pharmaceutical research; pharmaceutical research and development; pharmaceutical testing; product development consultancy for inventors in the field of cellular biology; product development consultancy for inventors in the field of medicine; providing information about medical and scientific research in the field of pharmaceuticals; providing information and data relating to scientific and technological research and development; providing scientific research information in the field of pharmaceuticals; research and development for the pharmaceutical industry; research and development in the field of biomedicine; research and development in the field of microorganisms and cells; research and development in the field of pharmaceuticals; research and development of antibodies; research and development of chemical reagent antibodies and conjugate antibodies; research and development of conjugated antibodies; research and development of medicines; research and development of new products in the field of pharmaceuticals; research and development of vaccines; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services of new pharmaceutical products; research in the field of immunotolerance; research services in the field of proteins, antibodies, microorganisms and cells; research to develop new products; scientific and industrial research; scientific and medical research and development; scientific research; scientific research and development; scientific research for medical purposes; scientific research in the field of biotechnology; scientific research relating to chemistry; technical research; technical research in the field of pharmaceutical studies; technical testing services]

Type of Mark: Word

Date of Acceptance: March 2

Registration Advertised: Sept. 24

For further details contact LEGALVISION ILP Pty. Ltd. .

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2626152.

Disclaimer: Curated by HT Syndication.